Search Tag: preserved ejection fraction

Cardiology Management

#ESCCongress Preview: PARAGON-HF Trial

2019 10 Aug

Topline findings from the Phase III PARAGON-HF study have just been announced. Full results of the trial will be presented at the ESC Congress 2019 in September.  The  PARAGON-HF trial  in heart failure patients with preserved ejection fraction (HFPEF) investigates the safety and efficacy of sacubitril/valsartan versus the active comparator... Read more

Cardiology Management

#ESC2019 Preview: PARAGON-HF Trial

2019 03 Aug

Topline findings from the Phase III PARAGON-HF study have just been announced. Full results of the trial will be presented at the ESC Congress 2019 in September.  The PARAGON-HF trial in heart failure patients with preserved ejection fraction (HFPEF) investigates the safety and efficacy of sacubitril/valsartan versus the active comparator... Read more